Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Bipolar Disorder NOS: later-stage trial registry
2 of 3 indexed Bipolar Disorder NOS trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Bipolar Disorder NOS: 3 US clinical trials tracked, 2 recruiting.
Bipolar Disorder NOS is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is New York State Psychiatric Institute, running 1 of these trials.
Enrollment posture brief
Registry condition bipolar-disorder-nos
OPEN 2 | RECR 67% | LATE 2 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Bipolar Disorder NOS lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Bipolar Disorder NOS on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Bipolar Disorder NOS is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
University of California, Los Angeles
NCT06920940
Exercise and Olanzapine-samidorphan
New York State Psychiatric Institute
NCT06740890
Sensoril(Ashwaganhda)for Bipolar Disorder
University of Pittsburgh
NCT00761761
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Bipolar Disorder NOS records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Bipolar Disorder NOS trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Bipolar Disorder NOS page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Bipolar Disorder NOS trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- New York State Psychiatric Institute sponsors the most Bipolar Disorder NOS trials on record, review their full trial history before evaluating a specific study. See New York State Psychiatric Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bipolar Disorder NOS condition card totals 3 registered trials; most-linked intervention Sensoril; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.